Researchers at University of Tsukuba have pioneered a state-of-the-art wearable device capable of precisely and continuously measuring trace perspiration amounts. This innovative device is adept at ...

More than 8500 people are expected to die from melanoma in the US in 2026. Early detection dramatically improves survival, yet the tools for identifying suspicious lesions remain, well, cumbersome.

WINSTON-SALEM, N.C., Oct. 22, 2025 — Researchers at Wake Forest University School of Medicine have developed a groundbreaking, battery-free wearable patch that could help detect skin cancer earlier ...

FRANKLIN LAKES, N.J., July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination ...

For patients who need regular drug delivery and continuous monitoring, these devices significantly improve their quality of life. Instead of being connected to huge, line-powered devices, patients can ...

Becton, Dickinson and Company (BD) has announced a trial utilising the BD Libertas wearable injector for subcutaneous delivery of biologics. The decision to employ the injector in this first ...

This small, stretchy skin patch uses ultrasound to continuously monitor blood pressure deep inside the body. A comprehensive clinical validation on 117 subjects, including patients in the intensive ...

The selection of BD Libertas™ Wearable Injector for this pharma-sponsored trial follows successful outcomes from more than 50 BD-conducted pre-clinical and clinical studies, including a device ...